Companies: 10,795·Total market cap: $144.5T
Genomma Lab Internacional, S.A.B. de C.V.

Genomma Lab Internacional, S.A.B. de C.V.

GNMLFOTCHealthcare● Active
$0.95
$-0.13(-12.04%)
Market Cap$928865018
P/E Ratio
52W High$1.17
52W Low$0.91
Overview

Genomma Lab Internacional, S.A.B. de C.V. (GNMLF) Revenue

Annual & quarterly revenue history · segment & region breakdown

GNMLF · revenue · updated Jun 9, 2026

Core revenue metrics

Genomma Lab Internacional, S.A.B. de C.V. trailing twelve-month (TTM) revenue is $12.90B, a decrease of 5.83% year-over-year from $17.52B in FY2025.

TTM revenue
$12.90B
4-quarter sum · USD
YoY growth
-5.83%
vs FY2025 $17.52B
Price / sales
0.07×
mktCap ÷ TTM rev
Revenue per day
$35M
Est. TTM ÷ 365
Revenue / employee
$8037K
1605 employees
FY2025
$17.52B
FY2024
$18.61B
5Y CAGR
+2.5%
Fiscal year end
Dec 31
Currency
MXN · GAAP
Filing
10-K / 10-Q
Source: FMP · Genomma Lab Internacional, S.A.B. de C.V. SEC filings · GAAPUpdated: 2026-06-09

Revenue trend

20252006 · Annual
YoY revenue growth %
revenue trend · revenue chart · revenue by year · revenue history

Revenue history

Fiscal year endRevenueChangeGrowth
2025-12-31$17.52B-$1.08B-5.83%
2024-12-31$18.61B+$1.82B+10.87%
2023-12-31$16.78B-$0.13B-0.75%
2022-12-31$16.91B+$1.44B+9.28%
2021-12-31$15.47B+$1.62B+11.69%
2020-12-31$13.85B+$0.84B+6.43%
2019-12-31$13.02B+$1.19B+10.06%
2018-12-31$11.83B-$0.42B-3.42%
2017-12-31$12.25B+$0.93B+8.23%
2016-12-31$11.32B+$0.27B+2.48%
GNMLF revenue by year · GNMLF revenue history · GNMLF annual revenue data

Compare revenue vs peers

Drug Manufacturers - Specialty & Generic

Compare GNMLF revenue against listed peers. Click any row to open that company's revenue tab.

About Revenue & Reporting

Revenue (also called sales, net sales, or turnover) is the total income Genomma Lab Internacional, S.A.B. de C.V. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.

Genomma Lab Internacional, S.A.B. de C.V. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in MXN.

Data sourced from Genomma Lab Internacional, S.A.B. de C.V.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.

Figures tie to SEC 10-K/10-Q and FMP income-statement endpoints where noted.

Frequently asked questions

GNMLF revenue · 4 questions

GNMLF's trailing twelve-month (TTM) revenue is $12.90B. That is a decrease of 5.83% year-over-year from $17.52B in FY2025.

GNMLF revenueGNMLF annual revenuewhat is GNMLF revenueGNMLF TTM revenue

Source: FMP · Genomma Lab Internacional, S.A.B. de C.V. SEC filings · GAAP · Genomma Lab Internacional, S.A.B. de C.V. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026